SkinBioTherapeutics shortlisted for Biotech and Money 2017 Awards

Two research scientists looking at microscope slides

SkinBioTherapeutics shortlisted for Biotech and Money 2017 Awards

SkinBioTherapeutics plc a life science company focused on skin health, has been nominated as a finalist in the Life Science IPO of the Year category of the Biotech and Money 2017 Awards.

The 2017 Biotech and Money Assembly and Awards Gala Dinner celebrates the UK’s funding, finance and investment success in the life sciences sector over the past 12 months.

SkinBioTherapeutics has been nominated for its IPO in April 2017 which raised £4.5 million in funds to enable the development of its proprietary SkinBiotix® technology platform and to accelerate the clinical development of its main therapeutic candidates. Their aim is to target cosmetic products, infection control and dermatological conditions.

Important information

This information is of a general nature and does not constitute an offer to provide services.

The opinions and conclusions given here are those of Seneca Partners and are subject to change without notice.

The value of investments and/or any income arising from them may fluctuate.

Past performance is not necessarily a guide to future performance.

Important notice

The products and services shown on this website place capital at risk. Investors may receive less in returns than they have invested. Investments may not allow for capital to be withdrawn on demand. If an investment provides tax relief then this relief is subject to change and is dependant on personal circumstances. Any reference to past performance or forecasted performance is not a reliable indicator of future performance.

Seneca Partners recommends that any investor seeks specialised financial and/or tax advice before investing. Seneca Partners does not provide advice and the information on this website, including but not limited to news, should not be construed as such.

Please confirm that you understand this warning and wish to proceed.